Choosing treatment for patients with ductal carcinoma in situ: Fine tuning the University of Southern California/Van Nuys Prognostic Index

Journal of the National Cancer Institute - Monographs

Volumn , Issue 41, 2010, Pages 193-196

  Silverstein, Melvin J ^a,b   Lagios, Michael D ^c,d  

^a HOAG MEMORIAL HOSPITAL PRESBYTERIAN   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Breast Consultation Service   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CONTROLLED STUDY; DATA ANALYSIS; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RECURRENCE RISK; TUMOR VOLUME; UNITED STATES; UNIVERSITY; ADJUVANT THERAPY; AGED; ALGORITHM; BREAST TUMOR; CLINICAL TRIAL (TOPIC); FEMALE; FOLLOW UP; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NECROSIS; PATHOLOGY; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; RISK FACTOR; SEGMENTAL MASTECTOMY; STATISTICS; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; ALGORITHMS; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; NECROSIS; NEOPLASM RECURRENCE, LOCAL; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 78650700515     PISSN: 10526773     EISSN: 17456614     Source Type: Book Series    
DOI: 10.1093/jncimonographs/lgq040     Document Type: Article

References (9)

1. Carlson RW, Allred DC, Anderson BO, et al. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Fort Washington, PA: National Comprehensive Cancer Network; 2008. www.nccn.org. 2008. Accessed September 15, 2010.
2. Silverstein MJ. Predicting local recurrence in patients with ductal carcinoma in situ. In: Silverstein MJ, eds. Ductal Carcinoma In Situ of the Breast. 1st ed. Baltimore, MD: Williams and Wilkins; 1997:271-284.
3. Silverstein MJ. Prognostic factors and local recurrence in patient with ductal carcinoma in situ of the Breast. Breast J. 1998;4:349-362.
4. Silverstein MJ. The University of Southern California/Van Nuys prognostic index. In: Silverstein MJ, Recht A, Lagios M, eds. Ductal Carcinoma In Situ of the Breast.. 2nd ed. Philadelphia, PA: Lippincott, Williams and Wilkins; 2002:459-473.
5. Silverstein MJ, Poller D, Waisman J, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet. 1995;345(8950):1154-1157.
6. Silverstein MJ, Poller D, Craig P, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer. 1996;77(11):2267-2274.
7. Silverstein MJ. The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg. 2003;186(4):337-343.
8. Lester S, Bose S, Chen Y-Y, et al. Protocol for the Examination of Specimens From Patients With Ductal Carcinoma In Situ (DCIS) of the Breast. Northfield, IL: American College of Pathologists; 2009. http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2009/BreastDCIS_09protocol.pdf. Accessed January 6, 2010.
9. Lester S, Bose S, Chen Y-Y, et al. Protocol for the examination of specimens from patients with ductal carcinoma in situ (DCIS) of the Breast. Arch Pathol Lab Med. 2009;133(1):15-25.